An Italian program of external quality control for chromogranin A (CgA) assay: State of the art of CgA measurement

International Journal of Biological Markers

Volumn 20, Issue 4, 2005, Pages 264-268

  Paradiso, A ^a   Verderio, P ^b   Pizzamiglio, S ^b   Cortese, M E ^b   Marubini, E ^c   Dittadi, Ruggero ^d   Gion, M ^d   De Appollonia, L ^e  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Ospedale Civile   (Italy)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Chromogranin A; External quality control

Indexed keywords

CHROMOGRANIN A; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CLINICAL LABORATORY; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; ITALY; NEUROENDOCRINE TUMOR; PROTEIN ANALYSIS; QUALITY CONTROL; QUESTIONNAIRE; RADIOIMMUNOASSAY;

EID: 30844462126     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080502000410     Document Type: Article

References (7)

1. Paradiso A, Volpe S, Iacobacci A, et al. Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers 2002; 17: 201-14.
2. INQAT Group: Interobserver reproducibility of immunohistochemical her-2/neu evaluation in human breast cancer: the real-world experience. Int J Biol Markers 2004; 19: 147-54.
3. INQAT Group. Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III. Int J Biol Markers 2005; 20: 189-94.
4. INQAT Group: Quality control for histological grading in breast cancer: an Italian experience. Pathologica 2005; 97: 1-6.
5. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003; 348: 1134-49.
6. Ferrari L, Seregni E, Martinetti A, et al. Chromogranin A measurement in neuroendocrine tumors. Int J Biol Markers 1998; 13: 3-9.
7. Leon A, Torta M, Dittadi R, et al. Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study. Int J Biol Markers 2005; 20: 156-68.